Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
- Resource Type
- Article
- Source
- In
The Lancet Respiratory Medicine June 2022 10(6):566-572 - Subject
Primary Research Articles - Language
- ISSN
- 2213-2600